Michael A. Mcmanus's most recent trade in Novavax, Inc. was a trade of 700 Common Stock done . Disclosure was reported to the exchange on June 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 700 | 10,101 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 700 | 0 | - | - | Restricted Stock Units | |
| Eastern Co. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 25.38 per share. | 17 Dec 2021 | 763 | 18,452 (0%) | 0% | 25.4 | 19,365 | Common Stock |
| Eastern Co. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 24.98 per share. | 17 Sep 2021 | 796 | 17,689 (0%) | 0% | 25.0 | 19,884 | Common Stock |
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 3,450 | 9,401 (0%) | 0% | - | Common Stock | |
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jun 2021 | 3,450 | 3,450 | - | - | Restricted Stock Units | |
| Novavax, Inc. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 1,300 | 1,300 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 700 | 700 | - | - | Restricted Stock Units | |
| Eastern Co. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 33.39 per share. | 17 Jun 2021 | 580 | 16,893 (0%) | 0% | 33.4 | 19,366 | Common Stock |
| Eastern Co. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 26.49 per share. | 26 Mar 2021 | 732 | 16,313 (0%) | 0% | 26.5 | 19,391 | Common Stock |
| Novavax, Inc. | Michael A. Mcmanus | Director | Sale of securities on an exchange or to another person at price $ 220.57 per share. | 19 Mar 2021 | 3,000 | 5,951 (0%) | 0% | 220.6 | 661,710 | Common Stock |
| Novavax, Inc. | Michael A. Mcmanus | Director | Sale of securities on an exchange or to another person at price $ 221.40 per share. | 19 Mar 2021 | 1,000 | 8,951 (0%) | 0% | 221.4 | 221,400 | Common Stock |
| Eastern Co. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 25.19 per share. | 16 Dec 2020 | 615 | 15,581 (0%) | 0% | 25.2 | 15,492 | Common Stock |
| Eastern Co. | Michael A. Mcmanus | Director | Grant, award, or other acquisition of securities at price $ 22.33 per share. | 28 Sep 2020 | 890 | 14,966 (0%) | 0% | 22.3 | 19,874 | Common Stock |
| Novavax, Inc. | Michael A. Mcmanus | Director | Sale of securities on an exchange or to another person at price $ 146.00 per share. | 18 Aug 2020 | 8,000 | 9,951 (0%) | 0% | 146 | 1,168,000 | Common Stock |
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2020 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.60 per share. | 18 Aug 2020 | 4,000 | 17,951 (0%) | 0% | 27.6 | 110,400 | Common Stock |
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.60 per share. | 18 Aug 2020 | 4,000 | 13,951 (0%) | 0% | 27.6 | 110,400 | Common Stock |
| Novavax, Inc. | Michael A. Mcmanus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2020 | 4,000 | 0 | - | - | Stock Option (Right to Buy) |